Skip to main content
. 2018 Apr 4;11:106. doi: 10.3389/fnmol.2018.00106

Table 2.

ΔCt of analyzed miRNAs and two host genes.

ALS Ctrl
miRNA/gene ΔCtmin ΔCtmax Median ΔCt ΔCtmin ΔCtmax Median ΔCt
let-7b 0.65 3.79 2.32 3.68 8.69 5.93
miR-9 7.13 10.9 8.95 9.27 19.72 12.74
miR-124a 7.69 10.11 8.82 21.40 28.93 24.50
miR-132 5.66 8.69 6.68 6.33 12.19 8.85
miR-143 5.39 13.81 10.12 5.96 13.73 9.84
miR-206 10.60 16.39 11.65 12.59 18.66 15.94
miR-338 3.82 9.50 7.98 4.41 14.38 9.90
miR-451a −1.00 5.23 2.43 1.34 8.26 4.46
miR-638 1.16 4.05 2.76 4.76 9.02 6.65
miR-663a 1.47 3.48 2.38 2.10 6.81 4.36
DNM2 6.97 10.56 8.76 1.63 7.32 4.86
AATK 6.08 11.25 9.47 −0.89 15.50 12.07

ALS, amyotrophic lateral sclerosis patients; Ctrl, controls; Ct, threshold cycle; ΔCt, delta Ct; ΔCtmin, minimal ΔCt detected within a group; ΔCtmax, maximal ΔCt detected within a group; median ΔCt, median of all individual detected ΔCts between maximal and minimal ΔCts within the group of patients/controls.